Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,636,925
-$26,719,176 QoQ
Shares Held
106,157
-62.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#129
of 1,603 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$8,462,880
CallShares
54,000
PutValue
$24,824,448
PutShares
158,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. NVS ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
This page
|
106,157 | $16,636,925 |
All Filings in NVS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,824,448 | 158,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $8,462,880 | 54,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $16,636,925 | 106,157 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $43,356,101 | 283,837 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $6,690,450 | 43,800 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,283,100 | 8,400 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $5,363,143 | 38,900 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $220,592 | 1,600 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $205,184 | 1,600 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $3,949,792 | 30,800 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $90,358,893 | 746,706 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $3,727,108 | 30,800 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $120,663,165 | 1,082,375 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $14,681,916 | 131,700 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $2,997,148 | 30,800 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $3,531,114 | 30,700 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $11,502,000 | 100,000 | Put | Defined | 2024-11-14 | |
| 2023-12-31 | $1,867,945 | 18,500 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $1,884,410 | 18,500 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $18,461,819 | 181,247 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $91,453,320 | 906,286 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $44,440,764 | 440,400 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $1,702,000 | 18,500 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $166,643,924 | 1,811,347 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,030,176 | 705,800 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $49,383,697 | 649,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,460,436 | 301,200 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $13,374,163 | 152,900 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $69,127,112 | 794,930 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||